The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia

Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Terry Golombick, Terry Diamond
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/0814732a76e2415f9917f09397acc14f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0814732a76e2415f9917f09397acc14f
record_format dspace
spelling oai:doaj.org-article:0814732a76e2415f9917f09397acc14f2021-12-02T08:36:33ZThe potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia1177-54751177-5491https://doaj.org/article/0814732a76e2415f9917f09397acc14f2008-03-01T00:00:00Zhttp://www.dovepress.com/the-potential-role-of-curcumin-diferuloylmethane-in-plasma-cell-dyscra-a65https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a progressive neoplastic disease. MGUS occurs in association with a variety of other diseases and currently no treatment is recommended but rather “watchful waiting”. Given that the size of the M-protein is a risk factor for disease progression, early intervention with the aim of reducing the paraprotein load would provide an innovative therapeutic tool. Preliminary results from our pilot study show a drop of between 5% and 30% serum paraprotein in patients taking curcumin compared with patients on placebo. Curcumin is a diferuloylmethane present in extracts of the rhizome of the Curcuma longa plant. As a natural product, this has exciting potential in the treatment of plasma cell dyscrasias.Keywords: plasma cell dyscrasias, MGUS, myeloma, curcumin, paraproteinemia Terry GolombickTerry DiamondDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2008, Iss Issue 1, Pp 161-163 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Terry Golombick
Terry Diamond
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
description Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a progressive neoplastic disease. MGUS occurs in association with a variety of other diseases and currently no treatment is recommended but rather “watchful waiting”. Given that the size of the M-protein is a risk factor for disease progression, early intervention with the aim of reducing the paraprotein load would provide an innovative therapeutic tool. Preliminary results from our pilot study show a drop of between 5% and 30% serum paraprotein in patients taking curcumin compared with patients on placebo. Curcumin is a diferuloylmethane present in extracts of the rhizome of the Curcuma longa plant. As a natural product, this has exciting potential in the treatment of plasma cell dyscrasias.Keywords: plasma cell dyscrasias, MGUS, myeloma, curcumin, paraproteinemia
format article
author Terry Golombick
Terry Diamond
author_facet Terry Golombick
Terry Diamond
author_sort Terry Golombick
title The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
title_short The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
title_full The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
title_fullStr The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
title_full_unstemmed The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
title_sort potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/0814732a76e2415f9917f09397acc14f
work_keys_str_mv AT terrygolombick thepotentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia
AT terrydiamond thepotentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia
AT terrygolombick potentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia
AT terrydiamond potentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia
_version_ 1718398445723582464